• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENMARK DIAGNOSTICS, INC. BLOOD CULTURE IDENTIFICATION GRAM-POSITIVE (BCID-GP); GRAM-POSITIVE BACTERIA AND THEIR RESISTANCE MARKERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENMARK DIAGNOSTICS, INC. BLOOD CULTURE IDENTIFICATION GRAM-POSITIVE (BCID-GP); GRAM-POSITIVE BACTERIA AND THEIR RESISTANCE MARKERS Back to Search Results
Catalog Number 09556508001
Device Problem False Negative Result (1225)
Patient Problem Unspecified Infection (1930)
Event Date 10/07/2022
Event Type  Death  
Event Description
On november 1, 2022, genmark was advised of unexpected negative results for staphylococcus aureus on the eplex bcid-gp panel tested on (b)(6) 2022, where the eplex bcid-gp panel detected an unspeciated staphylococcus result.Culture performed on (b)(6) 2022 identified staphylococcus aureus.On november 3, 2022, during communication related to the investigation, genmark was advised that the patient associated with the result was deceased on (b)(6) 2022.Genmark was advised the eplex bcid-gp results were not reported to the physician; however, the customer declined to comment further on the impact of the eplex bcid-gp results.On november 29, 2022, the customer indicated that they would not provide any further information on the matter.Data was analyzed per internal procedures and confirmed robust internal controls were generated for the eplex bcid-gp run suggesting the consumable performed as expected.Review of the eplex gp panel test run information for this sample shows robust signal for staphylococcus and low level signal that did not breach threshold for staphylococcus aureus.This suggests the test performed as described in the package insert, where it indicates, the eplex bcid-gp panel staphylococcus result is based on four assays: the species-specific staphylococcus aureus, staphylococcus epidermidis and staphylococcus lugdunensis assays and a broad staphylococcus assay.The broad staphylococcus assay will detect each of the species targeted by the species-specific assays, but its primary purpose is to detect other staphylococcus species.If all four assays are negative, the staphylococcus result will be ¿not detected¿.If any of the four assays is positive, the staphylococcus result will be ¿detected¿.If only the staphylococcus assay is positive, an unspeciated staphylococcus has been detected.
 
Manufacturer Narrative
Analysis: internal review of qc release data for affected lot 91292929 confirms the consumable lot successfully met the established qc release specifications.Review of the eplex bcid-gp panel test run information demonstrates that the internal controls were valid.No run malfunction was observed and the eplex instrument (serial # (b)(4)) was working within design specifications.Conclusion: while a discrepant result was reported by the customer, no quality and/or performance issues have been identified for the affected eplex bcid-gp panel lot.Genmark¿s investigation suggests the panel functioned as intended, and in accordance with the genus and group target results interpretation described in the package insert.The eplex bcid-gp panel was appropriately used according to the product's intended use, which describes the assay as an aid in the diagnosis of bloodstream infection when used in conjunction with other clinical information.The results from the eplex bcid-gp panel are intended to be interpreted in conjunction with gram stain results and should not be used as the sole basis for diagnosis, treatment, or other patient management decisions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BLOOD CULTURE IDENTIFICATION GRAM-POSITIVE (BCID-GP)
Type of Device
GRAM-POSITIVE BACTERIA AND THEIR RESISTANCE MARKERS
Manufacturer (Section D)
GENMARK DIAGNOSTICS, INC.
5964 la place ct, suite 100
carlsbad CA 92008
Manufacturer Contact
alan maderazo
5964 la place ct, suite 100
na
carlsbad, CA 92008
7604484308
MDR Report Key15900949
MDR Text Key304678453
Report Number3008632402-2022-00075
Device Sequence Number1
Product Code PAM
UDI-Device Identifier00857167005320
UDI-Public00857167005320
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K181663
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/19/2023
Device Catalogue Number09556508001
Device Lot Number91292929
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/03/2022
Initial Date FDA Received12/01/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age61 YR
Patient SexMale
-
-